NFM-06. NF106: PHASE 2 TRIAL OF THE MEK INHIBITOR...

Neuro-Oncology 2018 / 06 Vol. 20; Iss. suppl_2

NFM-06. NF106: PHASE 2 TRIAL OF THE MEK INHIBITOR PD-0325901 IN ADOLESCENTS AND ADULTS WITH NF1-RELATED PLEXIFORM NEUROFIBROMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY

Weiss, Brian, Plotkin, Scott, Widemann, Brigitte, Tonsgard, James, Blakeley, Jaishri, Allen, Jeffrey, Schorry, Elizabeth, Korf, Bruce, Rosser, Tena, Goldman, Stewart, Vinks, Alexander, Cutter, Gary, D
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/noy059.514
Date:
June, 2018
File:
PDF, 87 KB
english, 2018
Conversion to is in progress
Conversion to is failed